(Q43571490)

24 November 2017

title

Vitreous concentration of topically applied brimonidine tartrate 0.2%. (English)

1 reference

24 November 2017

1 reference

Kent AR

1

1 reference

24 November 2017

Nussdorf JD

2

1 reference

24 November 2017

David R

3

1 reference

24 November 2017

Tyson F

4

1 reference

24 November 2017

Small D

5

1 reference

24 November 2017

Fellows D

6

1 reference

24 November 2017

publication date

1 April 2001

1 reference

24 November 2017

1 reference

24 November 2017

volume

108

1 reference

24 November 2017

issue

4

1 reference

24 November 2017

page(s)

784-787

1 reference

Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900654-0

7 January 2021

Quantitative study of collagen and elastin of the optic nerve head and sclera in human and experimental monkey glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900654-0

7 January 2021

From the lab to the clinic: activation of an alpha-2 agonist pathway is neuroprotective in models of retinal and optic nerve injury

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900654-0

7 January 2021

Effects of brimonidine 0.2% on blue-yellow perimetry of glaucomatous patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900654-0

7 January 2021

Alpha 2-adrenergic agonists induce basic fibroblast growth factor expression in photoreceptors in vivo and ameliorate light damage.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900654-0

7 January 2021

10.1016/S0161-6420(00)00654-0

Identifiers

DOI

1 reference

release_b2qpuiinard37gggwu2qn7mjma

24 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/b2qpuiinard37gggwu2qn7mjma

24 November 2022

mapped directly with Wikidata item

1 reference